Expression of Targets in Endometriotic Lesions
Official title: To Investigate the Expression of Target in Endometriotic Lesions
Run by Beijing Tsinghua Chang Gung Hospital · NCT07693283 · Data updated 2026-11-12
This study tests molecules in tissue from people with endometriosis to see how their levels differ between endometriotic lesions and normal tissue.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Beijing Tsinghua Chang Gung Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | April 13, 2026 |
| Main results expected | September 30, 2026 |
| Study ends | February 12, 2027 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT07693283 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women with pathologically confirmed endometriosis and complete clinical/pathology data who have undergone laparoscopy.
✕Probably not a fit
Patients whose tissue samples do not show differential expression or who lack complete data may not benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will perform retrospective molecular expression analysis on endometriosis tissue specimens to compare the levels of selected molecules with those in normal tissue. The study uses pathologically confirmed cases and existing clinical data to explore potential roles of these molecules in the disease’s development. No experimental interventions are planned; the analysis relies on previously collected samples. The goal is to gain insight into the biology of endometriosis and identify candidates for future research. The study is conducted at Beijing Tsinghua Changgung Hospital in Beijing.
Why it matters
Potential benefit: If successful, the findings could improve understanding of endometriosis biology and guide future biomarker or therapeutic research.
How similar studies have gone: Previous studies using retrospective tissue analysis have identified meaningful molecular differences in endometriosis, supporting the potential value of this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pathologically confirmed endometriosis via laparoscopy and histopathological examination * Complete clinical and pathological data available Exclusion Criteria: • History of any malignant tumor
Where it's running
-
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Lei Zhang — Beijing Tsinghua Changgeng Hospital
- Study coordinator: Lei Zhang
- Email: 461458953@qq.com
- Phone: +86 186 0113 0459
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.